SL
Seroba Life Sciences
Venture CapitalActiveSeroba is a life sciences venture capital firm, focused on investing in breakthrough healthcare technologies.
28
Investments
3
Exits
$500M
AUM
10.7%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Seroba Life Sciences.
Investment Thesis & Strategy
Seroba Life Sciences invests in various stages of biotech and healthcare companies with breakthrough technologies. They focus on life sciences and venture capital opportunities.
Investment Activity
Deals per year over the last 16 years
1
20071
20080
20090
20102
20111
20120
20130
20140
20151
20161
20170
20181
20190
20201
20211
2022Portfolio Companies
Selected investments from their portfolio of 28 companies
P
Precede Bio
Biotech · Series A, 2022
G
Genable Technologies
Biotech · Series A, 2021
O
Opsidio
Biotech · Series A, 2019
A
Abliva
Biotech · Series B, 2017
I
Inflazome
Biotech · Series A, 2016
P
Prothena
Biotech · Series A, 2012
I
InnoTech Alberta
Biotech · Seed, 2011
M
MBio Diagnostics
Biotech · Series A, 2011
O
Opsona Therapeutics
Biotech · Series A, 2008
A
Alimentary Health
Biotech · Series A, 2007
Notable Exits
CompanyTypeYearValue / Acquirer
Opsona TherapeuticsAcquisition2017—
Endo InternationalAcquisition2014—
Alimentary HealthAcquisition2011—
Frequently Asked Questions
Seroba Life Sciences focuses on Series A, Series B, Series C+ stage investments.